BCYC Q1 2021 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$374M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+60.1% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$16M-886.3% margin

Net Income

-$16M-895.5% margin

EPS (Diluted)

$-0.73

QoQ Revenue Growth

-53.0%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$224M

Total Liabilities

$82M

Stockholders' Equity

$142M

Cash & Equivalents

$196M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$1M	+60.1%
Gross Profit	$2M	-$7M	+127.2%
Operating Income	-$16M	-$12M	-37.6%
Net Income	-$16M	-$11M	-43.0%

Revenue Segments

Target Four Material Right

$300,000100%